BackAvid Bioservices Overview

Avid Bioservices Total Current Liabilities

Track Avid Bioservices's total current liabilities ($74M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$74.16M
↓ 3.61% YoYΔ $-2.78M vs prior year quarter

Peer trimmed avg / median

Loading

Avid Bioservices Total Current Liabilities History

Loading

Avid Bioservices vs. peers: Total Current Liabilities Comparison

Loading

Avid Bioservices Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Avid Bioservices (CDMO) FAQ

Avid Bioservices (CDMO) currently reports a total current liabilities of $74M as of October 2024. That compares with $77M in the prior-year period — down 3.6% year over year. Use the charts on this page to explore Avid Bioservices's total current liabilities history and peer comparisons.

Avid Bioservices's total current liabilities decreased from $77M to $74M — a 3.6% year-over-year decrease (period ending October 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Avid Bioservices reported $74M in total current liabilities as of October 2024. That compares with $77M in the prior-year period — down 3.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $74M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Avid Bioservices, and consider following CDMO for alerts when major investors trade the stock.

Avid Bioservices is classified in the Healthcare sector. On total current liabilities, it currently shows $74M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CDMO with unrelated industries.